Quantinno Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Quantinno Capital Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-121,270	Closed	-$4.88M	–	3441
2026 Q1	$4.88M	Buy	121,270 +89,507	+282%	+$1.93M	0.01%	1146
2025 Q4	$798K	Sell	31,763 -16,656	-34%	-$391K	﹤0.01%	1978
2025 Q3	$1.1M	Buy	+48,419	New	+$1.13M	﹤0.01%	1444

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quantinno Capital Management's APLS Position: Q2 2026 in Review

Quantinno Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 121,270 shares — an estimated $4.88M sold.

Quantinno Capital Management first reported a position in APLS in Q3 2025 and held it in 3 quarters. The position peaked at $4.88M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Quantinno Capital Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Quantinno Capital Management sold 121,270 Apellis Pharmaceuticals shares in Q2 2026, an estimated $4.88M.
Quantinno Capital Management first reported a position in Apellis Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Quantinno Capital Management's Apellis Pharmaceuticals position peaked at $4.88M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.